Mitochondrial calcium handling in normotensive and spontaneously hypertensive rats: Correlation with systolic blood pressure levels

Mitochondrion

Volumn 20, Issue , 2015, Pages 75-81

  Pardo, Alejandro Ciocci ^a   Rinaldi, Gustavo J ^a   Mosca, Susana M ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Ca2+ response; Ca2+ retention capacity; MPTP; SHR; WKY; m

Indexed keywords

CALCIUM ION; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM RETENTION CAPACITY; CALCIUM TRANSPORT; CARDIOVASCULAR PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; HEART DEPOLARIZATION; HEART MITOCHONDRION; HEART WEIGHT; HYPERTROPHIC INDEX; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; METABOLISM; MITOCHONDRION;

ANIMALS; BLOOD PRESSURE; CALCIUM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 84942739687     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.12.003     Document Type: Article

References (48)

1. Aguilera-Aguirre L., González-Hernández J.C., Pérez-Vázquez V., Ramírez J., Clemente-Guerrero M., Villalobos-Molina R., Saavedra-Molina A. Role of intramitochondrial nitric oxide in rat heart and kidney during hypertension. Mitochondrion 2002, 1(5):413-423.
2. Anderson S.E., Gray S.D., Atherley R., Cala P.M. Na-dependent changes in intracellular Ca in spontaneously hypertensive rat hearts. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 1999, 23(3):299-309.
3. Andrienko T.N., Picht E., Bers D.M. Mitochondrial free calcium regulation during sarcoplasmic reticulum calcium release in rat cardiac myocytes. J. Mol. Cell. Cardiol. 2009, 46(6):1027-1036.
4. Baines C.P. The molecular composition of the mitochondrial permeability transition pore. J. Mol. Cell. Cardiol. 2009, 46(6):850-857.
5. Baines C.P., Song C.X., Zheng Y.T., Wang G.W., Zhang J., Wang O.L., Guo Y., Bolli R., Cardwell E.M., Ping P. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 2003, 92(8):873-880.
6. Bernardi P., Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr. 1996, 28(2):131-138.
7. Boyman L., Williams G.S., Khananshvili D., Sekler I., Lederer W.J. NCLX: the mitochondrial sodium calcium exchanger. J. Mol. Cell. Cardiol. 2013, 59:205-213.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Das A.M., Harris D.A. Defects in regulation of mitochondrial ATP synthase in cardiomyocytes from spontaneously hypertensive rats. Am. J. Physiol. 1990, 259:H1264-H1269.
10. 2+ and the heart. Cell Calcium 2008, 44(1):77-91.
11. Dikalov S.I., Ungvari Z. Role of mitochondrial oxidative stress in hypertension. Am. J. Physiol. Heart Circ. Physiol. 2013, 305(10):H1417-H1427.
12. Emaus R.K., Grunwald R., Lemasters J.J. Rhodamine 123 as a probe of transmembrane potential in isolated rat liver mitochondria: spectral and metabolic properties. Biochim. Biophys. Acta 1986, 850:436-448.
13. Failli P., Ruocco C., Fazzini A., Giotti A. Calcium waves in unstimulated left ventricular cardiomyocytes isolated from aged spontaneously hypertensive and normotensive rats. Biochem. Biophys. Res. Commun. 1997, 237(1):103-106.
14. Fieni F., Lee S.B., Jan Y.N., Kirichok Y. Activity of the mitochondrial calcium uniporter varies greatly between tissues. Nat. Commun. 2012, 3:1317-1330.
15. 2+ uniporter complex. J. Mol. Cell. Cardiol. 2014, 10.1016/j.yjmcc.2014.11.015.
16. Fritz M., Rinaldi G. Blood pressure measurement with the tail-cuff method in Wistar and spontaneously hypertensive rats: influence of adrenergic- and nitric oxide-mediated vasomotion. J. Pharmacol. Toxicol. Methods 2008, 58:215-221.
17. Gedik N., Heusch G., Skyschally A. Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration. Arch. Med. Sci. 2013, 9(6):968-975.
18. 2+ signaling: old guests, new functions. Pflugers Arch. 2007, 455(3):375-396.
19. Griffiths E.J. Mitochondrial calcium transport in the heart: physiological and pathological roles. J. Mol. Cell. Cardiol. 2009, 46(6):789-803.
20. Gunter T.E., Pfeifer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 1990, 258:C755-C78624.
21. 2+ transport mechanisms. Biochim. Biophys. Acta 2009, 1787(11):1291-1308.
22. Halestrap A.P. What is the mitochondrial permeability transition pore?. J. Mol. Cell. Cardiol. 2009, 46(6):821-831.
23. Hickey A.J., Chai C.C., Choong S.Y., de Freitas Costa S., Skea G.L., Phillips A.R., Cooper G.J. Impaired ATP turnover and ADP supply depress cardiac mitochondrial respiration and elevate superoxide in nonfailing spontaneously hypertensive rat hearts. Am. J. Physiol. Cell Physiol. 2009, 297(3):C766-C774.
24. Hoppe U.C. Mitochondrial calcium channels. FEBS Lett. 2010, 584(10):1975-1981.
25. Javadov S., Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell. Physiol. Biochem. 2007, 20(1-4):1-22.
26. Kitiyakara C., Wilcox C.S. Antioxidants for hypertension. Curr. Opin. Nephrol. Hypertens. 1998, 7:531-538.
27. Korge P., Yang L., Yang J.H., Wang Y., Qu Z., Weiss J.N. Protective role of transient pore openings in calcium handling by cardiac mitochondria. J. Biol. Chem. 2011, 286(40):34851-34857.
28. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87(1):99-163.
29. Lopez-Campistrous A., Hao L., Xiang W., Ton D., Semchuk P., Sander J., Ellison M.J., Fernandez-Patron C. Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension. Hypertension 2008, 51(2):412-419.
30. Mela L., Seitz S. Isolation of mitochondria with emphasis on heart mitochondria from small amounts of tissue. Methods Enzymol. 1979, 55:39-46.
31. Morota S., Manolopoulos T., Eyjolfsson A., Kimblad P.O., Wierup P., Metzsch C., Blomquist S., Hansson M.J. Functional and pharmacological characteristics of permeability transition in isolated human heart mitochondria. PLoS One 2013, 8(6):e67747.
32. Obame F.N., Plan-Mercier C., Assaly R., Zini R., Dubois-Randle J.L., Berdeaux A., Morin D. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J. Pharmacol. Exp. Ther. 2008, 326:252-258.
33. Orlov S.N., Pokudin N.I., Postnov Y.V. Ca-accumulating capacity of the cell membranes of the myocardium and smooth muscle in rats with spontaneous hypertension. Kardiologiia (Moscow) 1980, 2:94-100.
34. 2+ exchange. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(1):436-441.
35. 2+ influx mechanisms. Sci. China Life Sci. 2011, 54(8):763-769.
36. Postnov Y.V., Bakeeva L.E., Tsyplenkova V.G., Postnov A.Y. Ultrastructural alteration of mitochondria in cardiomyocytes of spontaneously hypertensive rats. Kardiologiia (Moscow) 2000, 40(1):55-63.
37. Postnov Y.V., Orlov S.N., Budnikov Y.Y., Doroschuk A.D., Postnov A.Y. Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension. Pathophysiology 2007, 14(3-4):195-204.
38. Redon J., Oliva M.R., Tormos C., Giner V., Chaves J., Iradi A., Saez G.T. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41:1096-1101.
39. Sang-Bing O., Hausenloy D.J. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 2010, 88(1):16-29.
40. Santo-Domingo J., Demaurex N. Calcium uptake mechanisms of mitochondria. Biochim. Biophys. Acta 2010, 1797(6-7):907-912.
41. Scaduto R.C., Grotyohann L.W. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 1999, 76:469-477.
42. 2+ in heart of spontaneous hypertensive rat. Fiziol. Zh. 2012, 58(6):3-8.
43. Sugiyama T., Yoshizumi M., Takaku F., Yazaki Y. Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats. J. Hypertens. 1990, 8:369-375.
44. Tang E.H., Leung F.P., Huang Y., Feletou M., So K.F., Man R.Y., Vanhoutte P.M. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br. J. Pharmacol. 2007, 151:15-23.
45. Tang Y., Mi C., Liu J., Gao F., Long J. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat. Cardiovasc. Pathol. 2014, 23(2):101-106.
46. Touyz R.M., Schiffrin E.L. Reactive oxygen species in vascular biology: implications in hypertension. Histochem. Cell Biol. 2004, 122:339-352.
47. Ward M.L., Crossman D.J., Loiselle D.S., Cannell M.B. Non-steady-state calcium handling in failing hearts from the spontaneously hypertensive rat. Pflugers Arch. 2010, 460(6):991-1001.
48. Williams S., Pourrier M., McAfee D., Lin S., Fedida D. Ranolazine improves diastolic function in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2014, 306(6):H867-H881.